Accumulating evidence shows a progressive decline in the efficacy of coronavirus disease
2019 (COVID‐19)(severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) …

Although universal vaccination is one of the most important healthcare strategies for limiting
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) circulation and averting the …

Studies on the humoral response to homologous BNT162b2 mRNA-vaccination focus
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …

Various commercial anti-Spike SARS-CoV-2 antibody tests are used for studies and in
clinical settings after vaccination. An international standard for SARS-CoV-2 antibodies has …

Vaccination plays a key role in tackling the ongoing SARS-CoV-2 pandemic but data
regarding the individual's protective antibody level are still pending. Our aim is to identify …

The kinetics of SARS-CoV-2 reactive IgG antibodies after full vaccination and booster in
allogeneic and autologous stem cell transplantation (allo-HSCT, ASCT) and chimeric …

The information provided by SARS‐CoV‐2 spike (S)‐targeting immunoassays can be
instrumental in clinical‐decision making. We compared the performance of the Elecsys® …

The rapid spread of SARS-CoV-2 caused the COVID-19 pandemic and accelerated vaccine
development to prevent the spread of the virus and control the disease. Given the sustained …

Individuals at increased risk for severe coronavirus disease-2019 (COVID-19) outcomes,
due to compromised immunity or other risk factors, would benefit from objective measures of …

There is an ongoing need for high-precision serological assays for the quantitation of anti-
SARS-CoV-2 antibodies. Here, a trimeric SARS-CoV-2 spike (S) protein was used to …